Skip to main content
. 2017 Nov 1;57(3):387–391. doi: 10.2169/internalmedicine.8335-16

Figure 2.

Figure 2.

Clinical course and changes in the anti-MDA5 antibody and serum ferritin levels. CADM: clinically amyopathic dermatomyositis, CyA: cyclosporin, IVCY: intravenous cyclophosphamide therapy, MDA5: melanoma differentiation-associated gene 5, mPSL: methylprednisolone, N/C: nasal cannula, HFNC: high-flow nasal cannula, PMX: polymyxin B direct hemoperfusion, RP-ILD: rapidly progressive interstitial lung disease, TAC: tacrolimus